Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01111877 · ClinicalTrials.gov registry record

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years

A clinical trial, sponsored by Alcon Research.

Terminated
Registry status
1,389
Enrollment target

NCT01111877: Clinical Trial study, sponsored by Alcon Research.

NCT01111877 is a clinical trial that was terminated before completion, run by Alcon Research. The registered enrollment target is 1,389 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01111877 was terminated before completion, sponsored by Alcon Research.

TERMINATED
Registry status
1,389 participants
Enrollment target

Study Summary

This study was conducted to describe the time to first incidence of otorrhea post tympanostomy tube insertion.

Trial Details

FieldValue
Enrollment Target 1,389 participants
Start Date 2010-05
Est. Completion 2011-11
Alcon Research

275 total trials

Why NCT01111877 stopped before completion

NCT01111877 is an observational study that tracks outcomes without assigning an intervention. Its 1,389 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01111877 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01111877 about?

NCT01111877 is a clinical study titled "Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in Children 6 Months to 12 Years". This study was conducted to describe the time to first incidence of otorrhea post tympanostomy tube insertion.

What is the current status of trial NCT01111877?

This trial is currently terminated. The enrollment target is 1,389 participants. The study started on 2010-05. Estimated completion is 2011-11.

Who is sponsoring clinical trial NCT01111877?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05006131 · 1,395 participants

    Pancreatic Cancer Screening for At-risk Individuals

  • NCT06651281 · 1,380 participants · Phase 3

    Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • NCT02205762 · 1,400 participants · Phase 2

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

  • NCT02445222 · 1,400 participants · Phase 3

    CAR-T Long Term Follow Up (LTFU) Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01111877, the US trial registry maintained by the National Library of Medicine. NCT01111877 (large enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.